A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?

The role of immune checkpoint inhibition (ICI) in the treatment of prostate cancer (PC) still remains elusive. It has been proposed that combination of ICI with other molecules increases the efficacy of immunotherapy in PC. To systematically review the literature to assess the potential role of ICI...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European urology oncology 2021-10, Vol.4 (5), p.745-754
Hauptverfasser:	Heidegger, Isabel, Necchi, Andrea, Pircher, Andreas, Tsaur, Igor, Marra, Giancarlo, Kasivisvanathan, Veeru, Kretschmer, Alexander, Mathieu, Romain, Ceci, Francesco, van den Bergh, Roderick C.N., Thibault, Constance, Tilki, Derya, Valerio, Massimo, Surcel, Christian, Gandaglia, Giorgio
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - therapeutic use Combination therapies Humans Immune Checkpoint Inhibitors Immunotherapy Male Metastatic castration-resistant prostate cancer Prostatic Neoplasms, Castration-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!